Tata Mutual Fund Pharma Fund - Regular Plan - Growth

Tata Mutual Fund Pharma Fund - Regular Plan - Growth complete review for investors

Tata Mutual Fund Pharma Fund - Regular Plan - Growth ek equity mutual fund hai jo healthcare sector mein invest karta hai. Iska objective hai investors ko long-term capital appreciation provide karna, khaas taur par un logon ke liye jo pharma aur healthcare companies mein invest karna chahte hain. Ye fund un investors ke liye suitable hai jo risk tolerate kar sakte hain aur unhe market volatility se dar nahi lagta. Agar aap SIP investing se long-term wealth creation ki soch rahe hain, toh ye fund aapke liye sahi ho sakta hai. Chaliye, is fund ke baare mein aur detail mein dekhte hain.

Tata Mutual Fund Pharma Fund - Regular Plan - Growth ke returns – 1, 3, 5 saal ke aankde

Agar hum returns ki baat karein toh is fund ne pichle 1 saal mein -0.49% ka return diya hai, jo benchmark Nifty Pharma TRI se thoda kam hai. Lekin 3 saal ki baat karein toh is fund ka return 15.62% hai, jo kaafi achha hai, aur 5 saal ka return 14.89% hai. Ye data indicate karta hai ki pichle kuch saalon mein is fund ne consistency dikhayi hai. Fund manager Sonam Udasi ne 3.5 saal se is fund ko manage kiya hai, aur unka experience is fund ki performance mein ek significant impact dalta hai. Agar hum is fund ko compare karein, toh ye sector ke doosre funds se kaafi competitive hai, lekin market volatility ke dauran investors ko careful rehna padega. Stable returns ke liye, agar aap long-term investment ki soch rahe hain, toh ye fund ek achha option ho sakta hai. Lekin short-term volatility ko madde nazar rakhte hue, aapko apne financial goals ke hisaab se decision lena chahiye.

Tata Mutual Fund Pharma Fund - Regular Plan - Growth ke top holdings aur portfolio

Tata Mutual Fund Pharma Fund - Regular Plan - Growth ke top 5 holdings mein kuch prominent names hain jaise Sun Pharmaceutical Industries Ltd. (20.5%), Dr. Reddy's Laboratories Ltd. (12.8%), Cipla Ltd. (10.4%), Divi's Laboratories Ltd. (9.8%), aur Torrent Pharmaceuticals Ltd. (7.2%). Is fund ka portfolio healthcare sector mein diversified hai, jo ki aapke investment ko ek strong foundation provide karta hai. Iska sector allocation mostly pharma companies mein hai, jo growth potential kaafi achha hai. Iska strategy bhi isi hi sector ko target karna hai, jo long-term investors ke liye faydemand ho sakta hai.

Tata Mutual Fund Pharma Fund - Regular Plan - Growth riskometer and downside risk

Is fund ka riskometer "Very High" hai, jo indicate karta hai ki ismein investment karne se investors ko high volatility face karni pad sakti hai. Historical performance se pata chalta hai ki healthcare sector market ke fluctuations ke dauraan kaafi unstable ho sakta hai. Agar aapka risk profile conservative hai, toh ye fund shaayad aapke liye theek nahi hoga. Sharpe ratio ki data available nahi hai, lekin generally, high risk ke saath high returns ka potential hota hai. Toh, ye fund un investors ke liye best hai jo higher risk appetite rakhte hain.

Tata Mutual Fund Pharma Fund - Regular Plan - Growth advantages and disadvantages

• Pros:
  • Strong historical performance, especially in the long term.
  • Diversified portfolio in the healthcare sector.
  • Professional management by experienced fund manager.
  • Potential for high growth given the sector's nature.
• Cons:
  • High risk and volatility, may not suit conservative investors.
  • 1-year performance is underwhelming compared to benchmarks.
  • Expense ratio of 1.95% is relatively high.